MCP Danish Cancer Society
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lovato, L.
Right arrow Articles by Bonetti, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovato, L.
Right arrow Articles by Bonetti, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on June 13, 2007
Revised on April 23, 2008
Accepted on July 31, 2008

Transketolase and CNPase I are specifically recognized by IgG autoantibodies in multiple sclerosis patients

Laura Lovato, Riccardo Cianti, Beatrice Gini, Silvia Marconi, Laura Bianchi, Alessandro Armini, Elena Anghileri, Francesca Locatelli, Francesco Paoletti, Diego Franciotta, Luca Bini, and Bruno Bonetti

Department of Neurological Sciences and Vision, University of Verona, Verona 37134

Corresponding Author: bruno.bonetti{at}univr.it

The presence of autoantibodies in multiple sclerosis (MuS) is well known, but their target antigens have not been clearly identified. In the present study, IgG autoreactivity to neural antigens of normal human white matter separated by bi-dimensional electrophoresis was assessed in serum and cerebro-spinal fluid (CSF) of 18 MuS and 20 control patients. Broad IgG autoreactivity was detected by 2D-immunoblotting in all cases to neural antigens, most of which have been identified by mass spectrometry. The comparative analysis of MuS and non-MuS reactive spots showed that a restricted number of neural protein isoforms was specifically recognized by MuS IgG. Almost all MuS patients had CSF IgG directed to isoforms of one of the oligodendroglial molecules transketolase (TK), cyclic nucleotide phosphodiesterase type I (CNPase I), collapsin response mediator protein 2 and tubulin beta4. Interestingly, 50% of MuS IgG recognized TK, which was mostly localized on oligodendrocytes in human white matter from normal and MS samples. IgG autoreactivity to cytoskeletal proteins (radixin, sirtuin 2 and actin interacting protein 1) was prevalent in secondary progressive MuS patients. Among the proteins recognized by serum IgG, almost all MuS patients specifically recognized a restricted number of neuronal/cytoskeletal proteins, while CNPase I was the oligodendroglial antigen most frequently recognized (44%) by MuS seric IgG. Our immunomic approach shed new light on the autoimmune repertoire present in MuS patients revealing novel oligodendroglial and/or neuronal putative autoantigens, with potential important pathogenic and diagnostic implications.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.